COMPARATIVE EVALUATION OF LIDOCAINE AND BUPIVACAINE FOR PAIN MANAGEMENT IN ENDODONTIC THERAPY OF IRREVERSIBLE PULPITIS

Authors

  • Fawad Ali Shah Department of Operative Dentistry, Khyber College of Dentistry, Peshawar, Pakistan.
  • Shafqat Ali Shah Department of Operative Dentistry, Khyber College of Dentistry, Peshawar, Pakistan.
  • Sumbal Khan Department of Operative Dentistry, Khyber College of Dentistry, Peshawar, Pakistan.
  • Samar Kamran Department of Oral Biology, Khyber Medical University, Peshawar, Pakistan.
  • Farhan Dil Department of Oral Biology, Khyber College of Dentistry, Peshawar, Pakistan.

DOI:

https://doi.org/10.33279/jkcd.v15i03.944

Keywords:

Endodontics anesthesia, Lidocaine, Bupivacaine and Irreversible pulpitis

Abstract

Objectives: The aim of this study is to compare the ability of lidocaine and bupivacaine to relieve pain during the treatment of irreversible pulpitis in endodontics.
Materials and Methods: The research involved 66 patients with symptomatic irreversible pulpitis, who received treatment at a dental hospital. Local anesthetic agents, lidocaine and bupivacaine, were randomized and given to individual patients in Groups A and B, respectively. Patient data included demographics and quadrant of teeth, as well as information on how much relief was noticed by report of dental pain. Data was analyzed in SPSS 22 to find out if there were any differences in anesthetic success rates between the two groups and among subgroups divided by age, gender, tooth location and periapical status.
Results: For anesthetic effectiveness, bupivacaine worked significantly better (63.6%) than lidocaine (36.4%) (P = 0.02). The findings showed the advantages of bupivacaine in younger (18–35 years), male patients and teeth that are in the front of the mouth. Overall, using bupivacaine offered better anesthesia in cases with and without periapical symptoms, along with better intraoperative comfort and reduced pain.
Conclusion: Clinicians could use bupivacaine in treating patients with root canal therapy to help patients have less pain, a better experience and not needing multiple injections which benefits their treatment.

References

Wei X, Ran S, Yan X, Huang J, Xue L, He TC, et al. Pyroptosis in Pulpitis. J Infl amm Res [Internet]. 2025 [cited 2025 Jun 22];18:5867–79. Available from: http://www.ncbi.nlm.nih.gov/pubmed/40322528

Wang B, Li W, Huang W, Li X, Li J, Shi S, et al. Multiple cell death modalities and immune response in pulpitis. Int Endod J [Internet]. 2025 Jan 1 [cited 2025Jun 22];58(1):111–27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/39257034

Santagostino SF, Assenmacher CA, Tarrant JC, Adedeji AO, Radaelli E. Mechanisms of Regulated Cell Death: Current Perspectives. Vet Pathol. 2021 Jul1;58(4):596–623.

Afkhami F, Pirmoazen S, Ardestani A, Fard MJK. Comparative evaluation of anesthetic efficacy of inferior alveolar nerve block and inferior alveolar nerve block plus buccal or lingual infiltration using articaine in mandibular molars with irreversible pulpitis: a preliminary prospective randomized single-blind clinical trial. Quintessence Int (Berl) [Internet]. 2021 Sep 9 [cited 2025 Jun 22];52(9):820–6. Available from: https://pubmed.ncbi.nlm.nih.gov/34369941/

Edwards D, Allison JR, Coulter J, Durham J, Beecroft E V. Symptomatic irreversible pulpitis and other orofacial pain: overcoming challenges in diagnosis and management. Br Dent J [Internet]. 2025 Apr 11 [cited2025 Jun 22];238(7):517–26. Available from: https://pubmed.ncbi.nlm.nih.gov/40217034/

Hassan S, Ahmed A, Saqib W, Abulhamael AM, Habib SR, Javed MQ. Comparison of Effi cacy of Lidocaine and Articaine as Inferior Alveolar Nerve Blocking Agents in Patients with Symptomatic Irreversible Pulpitis: Randomized Controlled Trial. Medicina (Lithuania) [Internet]. 2023 Oct 1 [cited 2025 Jun 22];59(10). Available from: https://pubmed.ncbi.nlm.nih.gov/37893558/

Saatchi M, Mohammadi G, Iranmanesh P, Khademi A, Farhad A, Aggarwal V, et al. Articaine buccal infi ltration for mandibular fi rst molars with symptomatic irreversible pulpitis: is it as effective as inferior alveolar nerve block with lidocaine? a systematic review and meta-analysis. Clin Oral Investig [Internet]. 2025 Feb 21 [cited 2025 Jun 22];29(3):146. Available from: http://www.ncbi.nlm.nih.gov/pubmed/39982504

Gupta A, Sahai A, Aggarwal V, Mehta N, Abraham D, Jala S, et al. Anesthetic effi cacy of primary and supplemental buccal/lingual infiltration in patients with irreversible pulpitis in human mandibular molars: a systematic review and meta-analysis. J Dent Anesth Pain Med [Internet]. 2021 Aug [cited 2025 Jun22];21(4):283–309. Available from: http://www.ncbi.nlm.nih.gov/pubmed/34395897

Ghani B. Determination of Anesthetic Efficacy of Lidocaine Versus Bupivacaine in Single Visit Root Canal Treatment. Eur Endod J. 2020;

Jouhar R, Ahmed MA, Ghani B. Determination of Anesthetic Effi cacy of Lidocaine Versus Bupivacaine in Single Visit Root Canal Treatment. Eur Endod J.2020;5(2):68–72.

Gülnahar Y, Alpan AL, Gülnahar E. Articaine versus lidocaine inferior alveolar nerve block in posterior mandible implant surgeries: a randomized controlled trial. Med Oral Patol Oral Cir Bucal [Internet]. 2023 Mar 1 [cited 2025 Jun 22];28(2):e108–15. Available from:https://pubmed.ncbi.nlm.nih.gov/36806026/

Falatah AM, Almalki RS, Al-Qahtani AS, Aljumaah BO, Almihdar WK, Almutairi AS. Comprehensive Strategies in Endodontic Pain Management: An Integrative Narrative Review. Cureus [Internet]. 2023 Dec 12 [cited 2025 Jun 22];15(12):e50371. Available from: http://www.ncbi.nlm.nih.gov/pubmed/38213339

Khan Q, Noor N, Anayat N, Khan TS, Ahmed M. Comparison of anaesthetic effi cacy of articaine and lidocaine in nonsurgical endodontic treatment of permanent mandibular molars with symptomatic irreversible pulpitis. a randomized clinical trial. Journal of Ayub Medical College. 2021;33(2):192–7.

Grant R, Brown T, Young L, Lamont T. How can local anaesthesia be improved in the management of irreversible pulpitis? Evid Based Dent [Internet]. 2021 Jan 1 [cited 2025 Jun 22];22(1):26–7. Available from: https://pubmed.ncbi.nlm.nih.gov/33772128/

Edwards D, Allison JR, Coulter J, Durham J, Beecroft EV. Symptomatic irreversible pulpitis and other orofacialpain: overcoming challenges in diagnosis and management. Br Dent J. 2025 Apr 11;238(7):517–26.

Edwards D, Rasaiah S, Kirkevang LL, Vaeth M, Stone SJ, Obara I, et al. The use of medicaments in the management of symptomatic irreversible pulpitis: A community-based cohort study. Int Endod J [Internet]. 2024 Apr 1 [cited 2025 Jun 22];57(4):416–30. Available from:https://pubmed.ncbi.nlm.nih.gov/38214015/

Yang F, Gao Y, Zhang L, Zheng B, Wang L, Sun H, et al. Local anaesthesia for surgical extraction of mandibular third molars: a systematic review and network meta-analysis. Clin Oral Investig [Internet]. 2020 Nov 1 [cited 2025 Jun 22];24(11):3781–800. Availablefrom: https://pubmed.ncbi.nlm.nih.gov/32833132/

Downloads

Published

2025-09-30

How to Cite

Shah, F. A. ., Shah, S. A. ., Khan, S., Kamran, S. ., & Dil, F. (2025). COMPARATIVE EVALUATION OF LIDOCAINE AND BUPIVACAINE FOR PAIN MANAGEMENT IN ENDODONTIC THERAPY OF IRREVERSIBLE PULPITIS. JOURNAL OF KHYBER COLLEGE OF DENTISTRY, 15(03), 2–7. https://doi.org/10.33279/jkcd.v15i03.944

Most read articles by the same author(s)